Imupharm Immune Health Onco Nutrition Heart Health Endocrine Health Joint and Bone Health Digestive Support Men's Health Women's Health Detox Support

Advanced Integrative Immunotherapy for Cancer





Modified Citrus Pectin

Other Ingredients: Hydroxypropyl methylcellulose, microcrystalline cellulose, L-leucine.

SUGGESTED USE: As a dietary supplement, 3 capsules one or two times daily, or as directed by a health practitioner.

This nutrient is of the highest quality and purity obtainable, free of all common allergens (antigens), and does not contain preservatives, diluents, or artificial additives.

Keep in a cool, dry place, tightly capped.

DISCLAIMER: The information contained on this web site has not been evaluated by the FDA. It is not intended to treat, diagnose, cure or prevent any disease. Material on the Imupharm web site is provided for educational purposes only. Always seek the advice of your physician or other qualified health care provider with any questions you have regarding a medical condition, and before undertaking any diet, exercise or other health program.

Modified citrus pectin, also known as fractionated pectin, is a complex polysaccahride taken from the peel and pulp of citrus fruits. It is different from other pectin because of the way it is prepared. It is modified by a proprietary process, which reduces the molecular weight of the pectin molecule. Derived from organic citrus pectin. Average molecular weight: 30kD; pH: 6.0-7.2; Methoxylation: not more than 5%. It is rich in galactoside residues, which give it an affinity for certain types of cancer cells. (Reference 1)

It has been shown to reduce metastases in prostate cancer. A study of men with recurrent prostate cancer and the effect of MCP after localized treatment (e.g. radical prostatectomy, radiation, or cryosurgery) suggests that MCP may lengthen the prostate specific antigen doubling time (PSADT) after localized treatment. (Reference 2)

Modified Pectin has been found to exhibit anti-mutagenic activity and inhibit cancer metastases and proliferation, with no evidence of toxicity or other serious side effects. A study investigated the inhibitory effect of pectin and suggests its importance in cancer chemoprevention and anti-inflammation. (Reference 3)

(1) Modified citrus pectin-monograph. Altern Med Rev. 2000 Dec;5(6):573-5.

(2) Guess BW, Scholz MC, Strum SB, Lam RY, Johnson HJ, Jennrich RI. Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study. Prostate Cancer Prostatic Dis. 2003;6(4):301-4.

(3) Chen CH, Sheu MT, Chen TF, Wang YC, Hou WC, Liu DZ, Chung TC, Liang YC. Suppression of endotoxin-induced proinflammatory responses by citrus pectin through blocking LPS signaling pathways. Biochem Pharmacol. 2006 Oct 16;72(8):1001-9. Epub 2006 Aug 22.